Bliss GVS Pharma Ltd. | Small-cap | Healthcare
₹157.68
5.96%
| Bliss GVS Pharma Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 8.1B
Gross Profit 4.0B 48.91%
Operating Income 972.7M 12.01%
Net Income 902.6M 11.15%
EPS (Diluted) ₹7.95

Balance Sheet Metrics

Total Assets 13.0B
Total Liabilities 2.1B
Shareholders Equity 10.9B
Debt to Equity 0.19

Cash Flow Metrics

Operating Cash Flow 604.4M
Free Cash Flow 296.3M

Revenue & Profitability Trend

Bliss GVS Pharma Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 8.1B 7.7B 7.5B 7.4B 5.7B
Cost of Goods Sold 4.1B 3.8B 4.0B 3.9B 3.3B
Gross Profit 4.0B 3.8B 3.5B 3.5B 2.4B
Operating Expenses 1.6B 1.3B 1.4B 1.4B 702.5M
Operating Income 972.7M 1.3B 1.0B 1.2B 910.0M
Pre-tax Income 1.3B 1.2B 1.1B 541.7M 1.0B
Income Tax 353.8M 352.9M 293.4M 310.4M 301.6M
Net Income 902.6M 815.8M 767.3M 231.3M 739.7M
EPS (Diluted) ₹7.95 ₹7.11 ₹6.72 ₹1.43 ₹6.49

Income Statement Trend

Bliss GVS Pharma Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 8.3B 8.1B 7.0B 7.8B 7.7B
Non-Current Assets 4.7B 4.0B 4.6B 3.3B 3.1B
Total Assets 13.0B 12.1B 11.6B 11.1B 10.8B
Liabilities
Current Liabilities 1.7B 1.6B 1.9B 2.3B 2.0B
Non-Current Liabilities 372.8M 510.6M 461.7M 292.0M 452.4M
Total Liabilities 2.1B 2.1B 2.4B 2.6B 2.5B
Equity
Total Shareholders Equity 10.9B 10.0B 9.2B 8.5B 8.3B

Balance Sheet Composition

Bliss GVS Pharma Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 1.3B 1.5B 1.1B 1.3B 1.0B
Operating Cash Flow 604.4M 1.7B 274.1M 1.8B 666.9M
Investing Activities
Capital Expenditures -726.5M -277.3M -931.1M -729.4M -87.0M
Investing Cash Flow -916.6M -1.4B 566.0M -1.2B -960.8M
Financing Activities
Dividends Paid -54.5M -53.9M -54.4M -53.3M -55.5M
Financing Cash Flow -190.4M -119.4M -172.7M -186.5M -177.8M
Free Cash Flow 296.3M 1.2B -594.9M 614.8M 548.5M

Cash Flow Trend

Bliss GVS Pharma Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 18.68
Price to Book 1.49
Price to Sales 1.93
PEG Ratio 1.71

Profitability Ratios

Profit Margin 10.41%
Operating Margin 6.59%
Return on Equity 8.62%
Return on Assets 4.84%

Financial Health

Current Ratio 4.81
Debt to Equity 8.07
Beta 0.97

Per Share Data

EPS (TTM) ₹7.95
Book Value per Share ₹99.37
Revenue per Share ₹77.04

Financial data is updated regularly. All figures are in the company's reporting currency.